Undefined Category

Third Quarter Results Show NHS in Need…

Quarterly Results published by Monitor and the NHS Trust Development Agency show serious financial pressures on NHS Foundation Trusts

NHS Improvement Announces New Chief Executive

Jim Mackey will start to bring together expert teams to deliver all of NHS Improvement's.

SurModics Receives FDA IDE Approval for Early…

The development of the SurVeil DCB is a major step forward.

Swiss Researchers Explore Benefits of Mediterranean Diet

First study of its kind in Switzerland explores lifestyle choices and how these impact on health

Reduction In Malaria Death Toll But Risk…

Malaria death rates have plunged by 60% since 2000.

Lipid Therapeutics Licenses Rights to its Novel…

Lipid Therapeutics today announced that it has entered into a licensing agreement with Nestl' Health Science

Health Secretary Outlines Vision for use of…

Patients will be able to access and interact with their GP record online within 12 months.

Apaziquone set for Phase Three Trial

Spectrum Pharmaceuticals announces agreement with FDA on the Special Protocol Assessment (SPA)

Accelerated Assessment for Ixazomib

European Medicines Agency Grants Accelerated Assessment of Ixazomib for Patients with Relapsed/Refractory Multiple Myeloma